Apogen Remedies Profile
Key Indicators
- Authorised Capital ₹ 15.00 Cr
as on 13-12-2024
- Paid Up Capital ₹ 14.80 Cr
as on 13-12-2024
- Company Age 13 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.00 Cr
as on 13-12-2024
- Satisfied Charges ₹ 5.00 Cr
as on 13-12-2024
- Revenue 1735894.48%
(FY 2021)
- Profit -2661.99%
(FY 2021)
- Ebitda 246.50%
(FY 2021)
- Net Worth -91.93%
(FY 2021)
- Total Assets 47.26%
(FY 2021)
About Apogen Remedies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 15.00 Cr and a paid-up capital of Rs 14.80 Cr.
The company currently has active open charges totaling ₹5.00 Cr. The company has closed loans amounting to ₹5.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Apogen Remedies Private Limited India is Abhishek Shukla as COMPANY SECRETARY. Bhanu Kommineni, Vikram Bery, Bala Thippabhotla, and One other member serve as directors at the Company.
- CIN/LLPIN
U24232TG2011PTC075363
- Company No.
075363
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Jul 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Medak, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Apogen Remedies Private Limited offer?
Apogen Remedies Private Limited offers a wide range of products and services, including API (Active Pharmaceutical Ingredients), Pharmaceutical Pellets, Pharma Ingredients & Raw Materials, Anti Infective API.
Who are the key members and board of directors at Apogen Remedies?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhishek Shukla  | Company Secretary | 23-Apr-2024 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bhanu Kommineni | Director | 05-Jul-2011 | Current |
Vikram Bery  | Director | 19-Jul-2019 | Current |
| Bala Thippabhotla | Director | 19-Jul-2019 | Current |
| Tamma Reddy | Director | 05-Jul-2011 | Current |
Financial Performance and Corporate Structure Insights of Apogen Remedies.
Apogen Remedies Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 1735894.48% increase. The company also saw a substantial fall in profitability, with a 2661.99% decrease in profit. The company's net worth observed a substantial decline by a decrease of 91.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Apogen Remedies?
In 2021, Apogen Remedies had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Bago Laboratories Private LimitedActive 22 years 11 months
Vikram Bery and Bala Thippabhotla are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 07 Feb 2020 | ₹5.00 Cr | Open |
Others Creation Date: 30 Mar 2016 | ₹5.00 Cr | Satisfied |
How Many Employees Work at Apogen Remedies?
Apogen Remedies has a workforce of 33 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Apogen Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apogen Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
